Meeting
2022 ASCO Annual Meeting
Functional impact of somatic mutations in early-onset (EO) versus average onset (AO) microsatellite stable (MSS) stage III colorectal cancer (CRC).
Authors
Emily Harrold
Memorial Sloan Kettering Cancer Centre, Dublin
Emily Harrold , Mark Solter , Henry S. Walch , Walid Khaled Chatila , Fergus Keane , Melissa Amy Lumish , Rona Yaeger , Jill A. Weiss , Randze Lerie Palmaira , Asha Krishnan , Luis A. Diaz Jr., Zsofia Kinga Stadler , Andrea Cercek
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer - Neo-Adjuvant/Adjuvant
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3613)
DOI
10.1200/JCO.2022.40.16_suppl.3613
Abstract #
3613
Poster Bd #
407
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparison of colorectal cancer (CRC) characteristics across genetic ancestries: Implications for early cancer detection (ECD).
First Author: Parvathi Myer
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
First Author: Patrick M Boland
Poster
2023 ASCO Annual Meeting
Characterization of MCL-1 in patients with colorectal cancer (CRC): Expression, molecular profiles, and outcomes.
First Author: Pooja Mittal